Robert Stanislaro | Managing Director | FTI Consulting
Search Our People
Rob Stanislaro

Robert Stanislaro

  • Managing Director
  • Strategic Communications
  • T: + 1 212 850 5657
  • F: +1 212 850 5790
Connect with Me:
    • Wall Street Plaza
    • 88 Pine Street, 32nd Floor
    • New York, NY, 10005
    • United States
    • T: +1 212 850 5600
    • F: +1 212 850 5790

Robert Stanislaro is a Managing Director in the FTI Consulting Strategic Communications segment and is based in New York.

Prior to his role at FTI Consulting, Mr. Stanislaro worked for nearly five years at Noonan Russo, the healthcare communications arm of Euro RSCG Life PR and one of the top 10 global networks in the field. While at Noonan Russo, he held a series of positions including senior account executive and account supervisor.

Mr. Stanislaro has significant experience in corporate communications—including messaging and positioning, thought leadership, and media relations—as well as capital markets communications, and issues management. His diverse experience working with healthcare and life sciences companies, and unique combination of scientific and business expertise enable him to counsel his clients on a variety of issues, which play a critical role in driving enterprise value.

Throughout his career, Mr. Stanislaro has developed communications programs for multi-billion dollar healthcare companies and medical societies including Shire Pharmaceuticals, Eli Lilly, Pfizer, Astellas, Quintiles, GE Healthcare, MGI PHARMA, Smith & Nephew and the American Society of Anesthesiologists. These programs have focused on positioning his clients as thought leaders in their respective industries, communicating through strategy transition periods, and supporting a number of inflection points including clinical trial results, product approvals and divestitures, financings, collaborations, mergers and acquisitions, peer-reviewed research and management changes. Mr. Stanislaro also has considerable experience working with emerging biotechnology and specialty pharma companies, such as GW Pharmaceuticals, TESARO, NicOx and CollaGenex Pharmaceuticals.

At FTI Consulting, Mr. Stanislaro develops communications programs for the firm's healthcare and life sciences’ companies, which are closely aligned to their business objectives. Several of these programs have been recognized by PR industry organizations.

Mr. Stanislaro holds an M.B.A. in marketing from Baruch College’s Zicklin School of Business and a B.S. in biology from Wagner College.

More Info

Share this page